三拗汤合四磨汤加减治疗肺痹病临床疗效分析

An analysis of clinical efficacy of the San’ao decoction and the Simo decoction on pulmonary arthralgia

目的:分析研讨三拗汤合四磨汤加减治疗肺痹病的临床疗效。方法:回顾分析我院2016年4月-2018年12月期间病情稳定的肺痹病患者60例,按治疗方式分对照组(30例接受三拗汤治疗)和研究组(30例接受三拗汤联合四磨汤治疗),比较两组治疗效果,以及治疗前后中医证候评分、肺功能指标、脉象功率谱能比(Pulse Power Spectrum Energy Ratio,PSR)指标。结果:研究组总疗效高于对照组(P<0.05);治疗前中医证候评分比较(P>0.05),治疗后,研究组气短、喘息、痰量、咳嗽等证候评分低于对照组(P<0.05);治疗前两组用力肺活量(Forced Vital Capacity,FVC)、第一秒用力呼气容积(Forced Expiratory Volume in 1 Second,FEV1)、第一秒用力呼气量占用力肺活量比值(FEV1/FVC)比较无明显差异(P>0.05),治疗后观察组FVC、FEV1明显高于对照组(P<0.05),而FEV1/FVC明显低于对照组(P<0.05);治疗前两组PSR1、PSR2、PSR3、PSR4比较无明显差异(P>0.05),治疗后观察组PSR1更高(P<0.05),而PSR2与PSR4更低(P<0.05),但两组PSR3比较无明显差异(P>0.05)。结论:肺痹病患者接受三拗汤联合四磨汤加减治疗,可显著改善其疾病症状,提高临床疗效,更好地改善肺功能指标与脉象指标,值得应用。

Objective:To analyze and discuss the clinical efficacy of the San’ao decoction(三拗汤)and the Simo decoction(四磨汤)on pulmonary arthralgia.Methods:60 patients were divided into the control group(30 patients,receiving the San’ao decoction)and research group(30 patients,receiving the San’ao decoction and the Simo decoction).Results:The total efficiency in the research group was higher than the control group(P<0.05).The scores of TCM syndromes showed differences between two groups(P<0.05).After treatment,FVC and FEV1 in the research group were significantly higher than the control group(P<0.05),and FEV1/FVC were significantly lower than the control group(P<0.05).PSR1 was higher in the observation group(P<0.05),while PSR2 and PSR4 were lower(P<0.05),but there was no significant difference in PSR3 between the two groups(P>0.05).Conclusion:The San’ao decoction and the Simo decoction can significantly improve disease symptoms,improve clinical efficacy,and better improve lung function indicators and pulse indicators,which are worthy of application.